MedPath

Transvaginal Ultrasonography Guided Embryo Transfer

Not Applicable
Completed
Conditions
Infertility, Female
Interventions
Procedure: transvaginal ultrasound guided embryo transfer
Procedure: transabdominal ultrasound guided embryo transfer
Registration Number
NCT03473028
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

to evaluate the value of using transvaginal ultrasound guided embryo transfer in obese patients undergoing in vitro fertilization.

Detailed Description

The 800 participants with body mass index more than 30kg/m2 were randomly allocated to two groups of equal size using an automated web-based randomization system. The first group 400 patient undergoing the transabdominal-guided embryo transfer, the second group 400 patient undergoing transvaginal-guided embryo transfer.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
800
Inclusion Criteria
  • BMI more than 35, good ovarian reserve, unexplained infertility more than 3 years.
Exclusion Criteria
  • severe male factor of infertility,uterine factor of infertility excluded by ultrasonography and hysteroscopy ,ovarian endometrioma or patients with poly cystic ovary syndrome, obesity caused by abnormal endocrine function (thyroid or adrenal disorder)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
transvaginal grouptransvaginal ultrasound guided embryo transfer400 obese female undergo transvaginal ultrasound guided embryo transfer
transabdominal ultrasoundtransabdominal ultrasound guided embryo transfer400 obese female undergo transabdominal ultrasound guided embryo transfer
Primary Outcome Measures
NameTimeMethod
clinical pregnancy rate'4 weeks following embryo transfer

the presence of at least one intrauterine gestational sac with viable fetus.

Secondary Outcome Measures
NameTimeMethod
live birth rateimmediately following delivery

delivery of a living baby

Trial Locations

Locations (1)

Kasr El Ainiy Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath